Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8A8W

Mycobacterium tuberculosis ClpC1 hexamer structure bound to the natural product antibiotic Ecumycin (class 1)

8A8W の概要
エントリーDOI10.2210/pdb8a8w/pdb
関連するPDBエントリー8A8U
EMDBエントリー15240 15242
分子名称ATP-dependent Clp protease ATP-binding subunit ClpC1, Bound polypeptide, ADENOSINE-5'-DIPHOSPHATE (3 entities in total)
機能のキーワードhexamer, tuberculosis, drug target, protein quality control, chaperone
由来する生物種Mycobacterium tuberculosis
詳細
タンパク質・核酸の鎖数7
化学式量合計574969.82
構造登録者
Felix, J.,Fraga, H.,Gragera, M.,Bueno, T.,Weinhaeupl, K. (登録日: 2022-06-24, 公開日: 2022-10-26, 最終更新日: 2024-07-24)
主引用文献Weinhaupl, K.,Gragera, M.,Bueno-Carrasco, M.T.,Arranz, R.,Krandor, O.,Akopian, T.,Soares, R.,Rubin, E.,Felix, J.,Fraga, H.
Structure of the drug target ClpC1 unfoldase in action provides insights on antibiotic mechanism of action.
J.Biol.Chem., 298:102553-102553, 2022
Cited by
PubMed Abstract: The unfoldase ClpC1 is one of the most exciting drug targets against tuberculosis. This AAA+ unfoldase works in cooperation with the ClpP1P2 protease and is the target of at least four natural product antibiotics: cyclomarin, ecumicin, lassomycin, and rufomycin. Although these molecules are promising starting points for drug development, their mechanisms of action remain largely unknown. Taking advantage of a middle domain mutant, we determined the first structure of Mycobacterium tuberculosis ClpC1 in its apo, cyclomarin-, and ecumicin-bound states via cryo-EM. The obtained structure displays features observed in other members of the AAA+ family and provides a map for further drug development. While the apo and cyclomarin-bound structures are indistinguishable and have N-terminal domains that are invisible in their respective EM maps, around half of the ecumicin-bound ClpC1 particles display three of their six N-terminal domains in an extended conformation. Our structural observations suggest a mechanism where ecumicin functions by mimicking substrate binding, leading to ATPase activation and changes in protein degradation profile.
PubMed: 36208775
DOI: 10.1016/j.jbc.2022.102553
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (4.29 Å)
構造検証レポート
Validation report summary of 8a8w
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon